New Mexico Department of Health reinforces hepatitis B vaccination within 24 hours of birth, diverging from CDC's delayed dose recommendation to protect newborns and reduce liver disease risks.

CDC advisory panel updates hepatitis B vaccine guidelines recommending shared clinical decision-making for newborns, while insurance coverage remains intact under ACA and Medicaid mandates.

New Jersey will continue recommending hepatitis B vaccination at birth for newborns, diverging from new federal panel advice suggesting delayed dosing. The state prioritizes early protection to reduce hepatitis B transmission and maintain insurance coverage standards.

The ACIP has revised its hepatitis B vaccination guidelines for newborns, shifting from universal birth dosing to selective administration based on maternal infection status, citing safety and parental consent concerns. This impacts CDC policy and health insurance coverage across the U.S.

CDC's vaccine advisory panel recommends limiting hepatitis B immunization at birth to infants born to hepatitis B positive or unknown status mothers, revising a 30+ year-old universal policy. The decision reflects shifting vaccine guidance and ongoing debates on vaccine safety and dosing.